Last Updated: September 24, 2026

Details for New Drug Application (NDA): 075987

✉ Email this page to a colleague

« Back to Dashboard

NDA 075987 describes OXAPROZIN, which is a drug marketed by Aarxion Anda Hlding, Actavis Elizabeth, Amneal Pharms Co, Chartwell, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan Pharms Inc, Pangea, Pharmobedient, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the OXAPROZIN profile page.

The generic ingredient in OXAPROZIN is oxaprozin. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.

Summary for 075987

Tradename:	OXAPROZIN
Applicant:	Chartwell
Ingredient:	oxaprozin
Patents:	0

Pharmacology for NDA: 075987

Mechanism of Action	Cyclooxygenase Inhibitors

Suppliers and Packaging for NDA: 075987

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
OXAPROZIN	oxaprozin	TABLET;ORAL	075987	ANDA	Chartwell RX, LLC.	62135-176	62135-176-18	180 TABLET in 1 BOTTLE (62135-176-18)
OXAPROZIN	oxaprozin	TABLET;ORAL	075987	ANDA	Chartwell RX, LLC.	62135-176	62135-176-60	60 TABLET in 1 BOTTLE (62135-176-60)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	600MG
Approval Date:	Sep 2, 2004	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.